FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Cécile Gouttefangeas

Research Profile

Chemicals & Drugs

Anatomy

Disorders

Procedures

Living Beings

Cytomegalovirus

Co-author Network

Publications

TOP 3
Helene Filbert; Cécile Gouttefangeas; Sylvia Janetzki; Christian H Ottensmeier; Bernhard Y Renard; Ugur Sahin; Sjoerd H van der burg; Marij J P Welters; Sebastian Attig; Nicole Bidmon; Cedrik Michael Britten
Serum-free freezing media support high cell quality and excellent ELISPOT assay performance across a wide variety of different assay protocols.
Satwinder Kaur Singh; Bart Tummers; Els Verdegaal; Marij J P Welters; Cedrik Michael Britten; Kees L M C Franken; Raquel Gomez; Cécile Gouttefangeas; Karoline Laske; Christian H Ottensmeier; Ton N Schumacher; Sjoerd H van der burg
The development of standard samples with a defined number of antigen-specific T cells to harmonize T cell assays: a proof-of-principle study.
Jens Bedke; Cécile Gouttefangeas; Stephan Kruck; Arnulf Stenzl
A vaccine in renal cell carcinoma: are we nearing reality?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Cécile Gouttefangeas (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Helene Filbert; Cécile Gouttefangeas; Sylvia Janetzki; Christian H Ottensmeier; Bernhard Y Renard; Ugur Sahin; Sjoerd H van der burg; Marij J P Welters; Sebastian Attig; Nicole Bidmon; Cedrik Michael Britten
Serum-free freezing media support high cell quality and excellent ELISPOT assay performance across a wide variety of different assay protocols.
Cancer immunology, immunotherapy : CII 2013;62(4):615-27.
2013: Satwinder Kaur Singh; Bart Tummers; Els Verdegaal; Marij J P Welters; Cedrik Michael Britten; Kees L M C Franken; Raquel Gomez; Cécile Gouttefangeas; Karoline Laske; Christian H Ottensmeier; Ton N Schumacher; Sjoerd H van der burg
The development of standard samples with a defined number of antigen-specific T cells to harmonize T cell assays: a proof-of-principle study.
Cancer immunology, immunotherapy : CII 2013;62(3):489-501.
2012: Jens Bedke; Cécile Gouttefangeas; Stephan Kruck; Arnulf Stenzl
A vaccine in renal cell carcinoma: are we nearing reality?
Expert review of anticancer therapy 2012;12(12):1503-5.
2012: Cedrik Michael Britten; L H Butterfield; G Ferrari; Cécile Gouttefangeas; A Hoos; C Huber; Sylvia Janetzki; Michael Kalos; Hyam I Levitsky; Holden T Maecker; C J M Melief; J O'Donnell-Tormey; Kunle Odunsi; L J Old; T H M Ottenhoff; C Ottensmeier; G Pawelec; M Roederer; B O Roep; P Romero; Sjoerd H van der burg; S Walter; M M Davis
T cell assays and MIATA: the essential minimum for maximum impact.
Immunity 2012;37(1):1-2.
2012: Marij J P Welters; Cedrik Michael Britten; Cécile Gouttefangeas; Anne Letsch; Christian H Ottensmeier; Tamara H Ramwadhdoebe; Sjoerd H van der burg
Harmonization of the intracellular cytokine staining assay.
Cancer immunology, immunotherapy : CII 2012;61(7):967-78.
2012: Melanie Widenmeyer; Alexei Y Sazykin; Arnulf Stenzl; Stefan Stevanović; Dorothee Wernet; Sebastian Attig; Susan Feyerabend; Cécile Gouttefangeas; Heinrich Griesemann; Jörg Hennenlotter; Reinhild Klein; Dmitri V Kuprash; Steve Pascolo; Hans-Georg Rammensee
Promiscuous survivin peptide induces robust CD4+ T-cell responses in the majority of vaccinated cancer patients.
International journal of cancer. Journal international du cancer 2012;131(1):140-9.
2012: Jens Bedke; Cécile Gouttefangeas; Arnulf Stenzl
[Prostate carcinoma: vaccination as a new option for treatment].
Der Urologe. Ausg. A 2012;51(1):44-9.
2011: Sjoerd H van der burg; Marij J P Welters; Cedrik Michael Britten; Cécile Gouttefangeas; Sylvia Janetzki; Michael Kalos; Christian Ottensmeier; Pedro Romero; Axel Hoos
Harmonization of immune biomarker assays for clinical studies.
Science translational medicine 2011;3(108):108ps44.
2011: Sebastian P Haen; Bora Kosan; Philippe L Pereira; Hermann Aebert; Andreas Boss; Stephan Clasen; Cécile Gouttefangeas; Diethard Schmidt; Alexandra von Herbay; Hans-Georg Rammensee
Elevated serum levels of heat shock protein 70 can be detected after radiofrequency ablation.
Cell stress & chaperones 2011;16(5):495-504.
2011: Melanie Widenmeyer; Yuriy Shebzukhov; Sebastian P Haen; Diethard Schmidt; Stephan Clasen; Andreas Boss; Dmitri V Kuprash; Sergei A Nedospasov; Arnulf Stenzl; Hermann Aebert; Dorothee Wernet; Stefan Stevanović; Philippe L Pereira; Hans-Georg Rammensee; Cécile Gouttefangeas
Analysis of tumor antigen-specific T cells and antibodies in cancer patients treated with radiofrequency ablation.
International journal of cancer. Journal international du cancer 2011;128(11):2653-62.
2011: Satwinder Kaur Singh; Karoline Laske; Cécile Gouttefangeas; Cedrik Michael Britten; Marij J P Welters
CIMT 2010: report on the eighth annual meeting of the Association for Cancer Immunotherapy, May 26-28, 2010, Mainz, Germany.
Cancer immunology, immunotherapy : CII 2011;60(3):443-50.
2010: Jacob Frelinger; Janet Ottinger; Cécile Gouttefangeas; Cliburn Chan
Modeling flow cytometry data for cancer vaccine immune monitoring.
Cancer immunology, immunotherapy : CII 2010;59(9):1435-41.
2010: Mustafa Diken; Melanie Widenmeyer; Cécile Gouttefangeas; Marij J P Welters; Cedrik Michael Britten
CIMT 2009: report on the seventh annual meeting of the association for immunotherapy of cancer. June 3-5, Mainz, Germany.
Cancer immunology, immunotherapy : CII 2010;59(9):1417-23.
2010: P Sáenz-López; Cécile Gouttefangeas; J Hennenlotter; Angel Concha; Isabel Maleno; Francisco Ruiz-Cabello; José Manuel Cózar; Miguel Tallada; A Stenzl; H-G Rammensee; Federico Garrido; Teresa Cabrera
Higher HLA class I expression in renal cell carcinoma than in autologous normal tissue.
Tissue antigens 2010;75(2):110-8.
2009: Sebastian Attig; Jörg Hennenlotter; Graham Pawelec; Gerd Klein; Sven D Koch; Hanspeter Pircher; Susan Feyerabend; Dorothee Wernet; Arnulf Stenzl; Hans-Georg Rammensee; Cécile Gouttefangeas
Simultaneous infiltration of polyfunctional effector and suppressor T cells into renal cell carcinomas.
Cancer research 2009;69(21):8412-9.
2009: Susan Feyerabend; Stefan Stevanovic; Cécile Gouttefangeas; Dorothee Wernet; Jörg Hennenlotter; Jens Bedke; Klaus Dietz; Steve Pascolo; Markus Kuczyk; Hans-Georg Rammensee; Arnulf Stenzl
Novel multi-peptide vaccination in Hla-A2+ hormone sensitive patients with biochemical relapse of prostate cancer.
The Prostate 2009;69(9):917-27.
2009: Christina Stoeckle; Cécile Gouttefangeas; Michael Hammer; Ekkehard Weber; Arthur Melms; Eva Tolosa
Cathepsin W expressed exclusively in CD8+ T cells and NK cells, is secreted during target cell killing but is not essential for cytotoxicity in human CTLs.
Experimental hematology 2009;37(2):266-75.
2008: Cedrik Michael Britten; Cécile Gouttefangeas; Marij J P Welters; Graham Pawelec; Sven Koch; C Ottensmeier; A Mander; S Walter; Annette Paschen; Jan Muller-Berghaus; I Haas; Andreas Mackensen; Tania Køllgaard; Per thor Straten; M Schmitt; K Giannopoulos; R Maier; Hendrik Veelken; Cristina Bertinetti; Abdo Konur; Christoph Huber; S Stevanović; Thomas Wölfel; Sjoerd H van der burg
The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays.
Cancer immunology, immunotherapy : CII 2008;57(3):289-302.
2008: Cedrik Michael Britten; Sylvia Janetzki; Sjoerd H van der burg; Cécile Gouttefangeas; A Hoos
Toward the harmonization of immune monitoring in clinical trials: quo vadis?
Cancer immunology, immunotherapy : CII 2008;57(3):285-8.
2008: Marij J P Welters; Cécile Gouttefangeas; Sebastian Attig; Sven Koch; Cedrik Michael Britten
Report on the Fifth Annual Meeting of the Association for Immunotherapy of Cancer (CIMT) April 12-14, 2007 in Würzburg, Germany.
Cancer immunology, immunotherapy : CII 2008;57(1):135-42.
2007: Sven Koch; Anis Larbi; Dennis Ozcelik; Rafael Solana; Cécile Gouttefangeas; Sebastian Attig; Anders Wikby; Jan Strindhall; Claudio Franceschi; Graham Pawelec
Cytomegalovirus infection: a driving force in human T cell immunosenescence.
Annals of the New York Academy of Sciences 2007;1114():23-35.
2007: Natalia Aptsiauri; Teresa Cabrera; Graham Pawelec; Cécile Gouttefangeas; Evelyna Derhovanessian; Federico Garrido; Angel Garcia-Lora
International conference: progress in vaccination against cancer-2006 (PIVAC 6), Granada, Spain.
Cancer immunology, immunotherapy : CII 2007;56(8):1311-22.
2007: Cécile Gouttefangeas; Cedrik Michael Britten; E Derhovanessian Badalians; Graham Pawelec
CIMT meets strategies for immune therapy. Report and abstracts of the 4th International Meeting of the Association for Immunotherapy of Cancer, Mainz, Germany, 4-5 May 2006.
Cancer immunology, immunotherapy : CII 2007;56(3):397-427.
2007: Cécile Gouttefangeas; Arnulf Stenzl; Stefan Stevanović; Hans-Georg Rammensee
Immunotherapy of renal cell carcinoma.
Cancer immunology, immunotherapy : CII 2007;56(1):117-28.
2006: Graham Pawelec; Sven Koch; H Griesemann; A Rehbein; K Hähnel; Cécile Gouttefangeas
Immunosenescence, suppression and tumour progression.
Cancer immunology, immunotherapy : CII 2006;55(8):981-6.
2006: Jörn Dengjel; Maria-Dorothea Nastke; Cécile Gouttefangeas; Gitsios Gitsioudis; Oliver Schoor; Florian Altenberend; Margret Müller; Björn Krämer; Anna Missiou; Martina Sauter; Jörg Hennenlotter; Dorothee Wernet; Arnulf Stenzl; Hans-Georg Rammensee; Karin Klingel; Stefan Stevanović
Unexpected abundance of HLA class II presented peptides in primary renal cell carcinomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(14 Pt 1):4163-70.
2006: Graham Pawelec; Cécile Gouttefangeas
T-cell dysregulation caused by chronic antigenic stress: the role of CMV in immunosenescence?
Aging clinical and experimental research 2006;18(2):171-3.
2006: Cedrik Michael Britten; Cécile Gouttefangeas; Sebastian Kreiter
Cancer immunotherapy 2005: Mainz, Germany, 12-13 May 2005.
Cancer immunology, immunotherapy : CII 2006;55(4):475-80.
2006: Philippe Pereira; Andreas Boss; Stephan Clasen; Cécile Gouttefangeas; Diethard Schmidt; Claus D Claussen
Radiofrequency ablation: the percutaneous approach.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2006;167():39-52.
2006: Graham Pawelec; Sven Koch; Cécile Gouttefangeas; Anders Wikby
Immunorejuvenation in the elderly.
Rejuvenation research 2006;9(1):111-6.
2005: Steffen Walter; Gilles Bioley; Hans-Jörg Bühring; Sven Koch; Dorothee Wernet; Alfred Zippelius; Graham Pawelec; Pedro Romero; Stefan Stevanović; Hans-Georg Rammensee; Cécile Gouttefangeas
High frequencies of functionally impaired cytokeratin 18-specific CD8+ T cells in healthy HLA-A2+ donors.
European journal of immunology 2005;35(10):2876-85.
2005: Jasmin Dittmann; Karin Keller-Matschke; Toni Weinschenk; Thomas Kratt; Tobias Heck; Horst D Becker; Stefan Stevanović; Hans-Georg Rammensee; Cécile Gouttefangeas
CD8+ T-cell response against MUC1-derived peptides in gastrointestinal cancer survivors.
Cancer immunology, immunotherapy : CII 2005;54(8):750-8.
2004: Graham Pawelec; Cécile Gouttefangeas
Strategies for immune therapy: Würzburg, Germany, 29 February-3 March 2004.
Cancer immunology, immunotherapy : CII 2004;53(8):755-8.
2004: Philippe Pereira; Stephan Clasen; Andreas Boss; D Schmidt; Cécile Gouttefangeas; C Burkart; Jakub Wiskirchen; Gunnar Tepe; Claus D Claussen
[Radiofrequency ablation of liver metastases].
Der Radiologe 2004;44(4):347-57.
2002: Toni Weinschenk; Cécile Gouttefangeas; Markus Schirle; Florian Obermayr; Steffen Walter; Oliver Schoor; Raffael Kurek; Wolfgang Loeser; Karl-Horst Bichler; Dorothee Wernet; Stefan Stevanović; Hans-Georg Rammensee
Integrated functional genomics approach for the design of patient-individual antitumor vaccines.
Cancer research 2002;62(20):5818-27.
2002: Hans-Georg Rammensee; Toni Weinschenk; Cécile Gouttefangeas; Stefan Stevanović
Towards patient-specific tumor antigen selection for vaccination.
Immunological reviews 2002;188():164-76.
2002: Karl S Lang; Arnaud Moris; Cécile Gouttefangeas; Steffen Walter; Volker Teichgräber; M Miller; Dorothee Wernet; Klaus Hamprecht; Hans-Georg Rammensee; Stefan Stevanovic
High frequency of human cytomegalovirus (HCMV)-specific CD8+ T cells detected in a healthy CMV-seropositive donor.
Cellular and molecular life sciences : CMLS 2002;59(6):1076-80.
2002: Norbert Hilf; Harpreet Singh-Jasuja; Petra Schwarzmaier; Cécile Gouttefangeas; Hans-Georg Rammensee; Hansjörg Schild
Human platelets express heat shock protein receptors and regulate dendritic cell maturation.
Blood 2002;99(10):3676-82.
2001: Cécile Gouttefangeas; M Eberle; Peter Ruck; M Stark; J E Müller; Horst D Becker; Hans-Georg Rammensee; Jürgen Pinocy
Functional T lymphocytes infiltrate implanted polyvinyl alcohol foams during surgical wound closure therapy.
Clinical and experimental immunology 2001;124(3):398-405.
2000: Markus Schirle; W Keilholz; B Weber; Cécile Gouttefangeas; Tilman Dumrese; Horst D Becker; S Stevanović; Hans-Georg Rammensee
Identification of tumor-associated MHC class I ligands by a novel T cell-independent approach.
European journal of immunology 2000;30(8):2216-25.
2000: Cécile Gouttefangeas; M Diehl; W Keilholz; R F Hörnlein; S Stevanović; Hans-Georg Rammensee
Thrombocyte HLA molecules retain nonrenewable endogenous peptides of megakaryocyte lineage and do not stimulate direct allocytotoxicity in vitro.
Blood 2000;95(10):3168-75.